TERAPI1.: Protection of Intellectual Property rights of new therapeutic agents against amyloid transthyretin diseases (Q2866969): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Removed claim: co-financing rate (P837): 50.0 percentage)
(‎Added qualifier: readability score (P590521): 0.000011549083729174788)
 
(6 intermediate revisions by 2 users not shown)
Property / beneficiary name (string)
BSIM THERAPEUTICS, S.A.
 
Property / beneficiary name (string): BSIM THERAPEUTICS, S.A. / rank
Normal rank
 
Property / beneficiary
Q2988326 (Deleted Item)
 
Property / beneficiary: Q2988326 (Deleted Item) / rank
Normal rank
 
Property / budgetProperty / budget
48,769.0 Euro
Amount48,769.0 Euro
UnitEuro
48,768.66 Euro
Amount48,768.66 Euro
UnitEuro
Property / EU contributionProperty / EU contribution
24,384.0 Euro
Amount24,384.0 Euro
UnitEuro
24,384.33 Euro
Amount24,384.33 Euro
UnitEuro
Property / summary: None (English) / qualifier
 
readability score: 0.000011549083729174788
Amount0.000011549083729174788
Unit1
Property / contained in Local Administrative Unit
 
Property / contained in Local Administrative Unit: União das freguesias de Cantanhede e Pocariça / rank
 
Normal rank
Property / priority axis
 
Property / priority axis: Research, Development and Innovation (DIIAS) / rank
 
Normal rank
Property / co-financing rate
 
50.0 percent
Amount50.0 percent
Unitpercent
Property / co-financing rate: 50.0 percent / rank
 
Normal rank
Property / thematic objective
 
Property / thematic objective: Research and innovation / rank
 
Normal rank
Property / beneficiary
 
Property / beneficiary: BSIM THERAPEUTICS, S.A. / rank
 
Normal rank
Property / beneficiary name (string)
 
BSIM THERAPEUTICS, S.A.
Property / beneficiary name (string): BSIM THERAPEUTICS, S.A. / rank
 
Normal rank
Property / date of last update
 
14 November 2023
Timestamp+2023-11-14T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / date of last update: 14 November 2023 / rank
 
Normal rank

Latest revision as of 16:30, 12 March 2024

Project Q2866969 in Portugal
Language Label Description Also known as
English
TERAPI1.: Protection of Intellectual Property rights of new therapeutic agents against amyloid transthyretin diseases
Project Q2866969 in Portugal

    Statements

    0 references
    24,384.33 Euro
    0 references
    48,768.66 Euro
    0 references
    50.0 percent
    0 references
    20 May 2017
    0 references
    19 May 2021
    0 references
    BSIM THERAPEUTICS, S.A.
    0 references

    40°21'55.76"N, 8°39'29.95"W
    0 references
    None (Estonian)
    29 July 2022
    0 references
    None (Lithuanian)
    29 July 2022
    0 references
    None (Italian)
    29 July 2022
    0 references
    None (French)
    29 July 2022
    0 references
    None (Croatian)
    29 July 2022
    0 references
    None (Greek)
    29 July 2022
    0 references
    None (English)
    29 July 2022
    0.000011549083729174788
    0 references
    None (Slovak)
    29 July 2022
    0 references
    None (Finnish)
    29 July 2022
    0 references
    None (Polish)
    29 July 2022
    0 references
    None (Hungarian)
    29 July 2022
    0 references
    None (Dutch)
    29 July 2022
    0 references
    None (Czech)
    29 July 2022
    0 references
    None (Latvian)
    29 July 2022
    0 references
    None (Irish)
    29 July 2022
    0 references
    None (Slovenian)
    29 July 2022
    0 references
    None (Spanish)
    29 July 2022
    0 references
    None (Bulgarian)
    29 July 2022
    0 references
    None (Maltese)
    29 July 2022
    0 references
    None (Portuguese)
    29 July 2022
    0 references
    None (Danish)
    29 July 2022
    0 references
    None (Romanian)
    29 July 2022
    0 references
    None (German)
    29 July 2022
    0 references
    None (Swedish)
    29 July 2022
    0 references
    Cantanhede
    0 references
    14 November 2023
    0 references

    Identifiers

    CENTRO-01-0247-FEDER-028007
    0 references